SGLT2 inhibitors for kidney and heart disease

Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease.

heart disease kidney disease SGLT2 inhibitors